Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Infections in Patients with Lymphoproliferative Diseases Treated with Target Therapy. Italian Multicentric Retrospective Study Seifem 2017

Gianpaolo Nadali, MD, Gessica Marchesini, MD, Davide Facchinelli, MD, Francesca Farina, MD, Maria Chiara Tisi, MD, Federica Lessi, MD, Francesco Marchesi, Chiara Cattaneo, MD, Anna Candoni, MD, Rosa Fanci, Lucia Prezioso, MD, Luisa Verga, MD, Luca Laurenti, MD, Fabio Trastulli, MD, Marco Picardi, MD, Maria Ilaria Del Principe, MD, Ronaldo Silva, PhD, Alessandro Busca

Blood (2018) 132 (Supplement 1): 4164.

https://doi.org/10.1182/blood-2018-99-111518

Published: 2018

Journal Articles

Clinical Relevance of NOTCH1 Mutations in Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL)

Blood (2018) 132 (Supplement 1): 4396.

https://doi.org/10.1182/blood-2018-99-113074

Published: 2018

Journal Articles

The Amount of Apoptosis Predicts Outcome in Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL)

Giovanni Del Poeta, MD, Massimiliano Postorino, MD, Federico Pozzo, PhD, Maria Ilaria Del Principe, MD, Enrico Santinelli, MD, Riccardo Bomben, PhD, Annalisa Biagi, MD, Francesco Buccisano, MD, Francesca Maria Rossi, PhD, Adriano Venditti, MD, Paolo de Fabritiis, MD, Maria Cantonetti, MD, Sergio Amadori, MD, Valter Gattei, MD, William Arcese

Blood (2018) 132 (Supplement 1): 4397.

https://doi.org/10.1182/blood-2018-99-113060

Published: 2018

Journal Articles

Clinical Significance of Occult Central Nervous System Disease in Adult ACUTE Lymphoblastic Leukemia. a Multicenter,Report from the Campus ALL/Gimema Network

Blood (2018) 132 (Supplement 1): 658.

https://doi.org/10.1182/blood-2018-99-114177

Published: 2018

Journal Articles

Real Life Use of Bendamustine Plus Rituximab Versus Chlorambucil Plus Rituximab As Front-Line Therapy for Elderly CLL Patients. Retrospective Multicenter Study in the Lazio Region

Francesco Autore, MD, Idanna Innocenti, MD PhD, Francesco Corrente, Maria Ilaria Del Principe, MD, Serena Rosati, MD, Paolo Falcucci, Esmeralda Conte, Maria Assunta Limongiello, Daniela Renzi, Laura De Padua, MD, Alessandro Andriani, MD, Francesco Pisani, MD, Giuseppe Cimino, Agostino Tafuri, MD, Marco Montanaro, MD, Francesca Romana Mauro, Giovanni Del Poeta, MD, Luca Laurenti, MD

Blood (2018) 132 (Supplement 1): 5550.

https://doi.org/10.1182/blood-2018-99-119408

Published: 2018

Journal Articles

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Blood (2016) 128 (22): 2789.

https://doi.org/10.1182/blood.V128.22.2789.2789

Published: 2016

Journal Articles

Low Bax/Bcl-2 Ratio and NOTCH1 Mutations Represent Powerful and Synergistic Adverse Prognostic Factors within Trisomy 12 Chronic Lymphocytic Leukemia (CLL)

Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Massimiliano Postorino, Michele Dal Bo, Maria Francesca Rossi, Francesco Buccisano, Luca Maurillo, MD, Davide Rossi, Livio Pupo, Benedetta Mariotti, Adriano Venditti, MD, Paolo de Fabritiis, MD, Maria Cantonetti, Gianluca Gaidano, Francesco Lo Coco, MD, Valter Gattei, Sergio Amadori, MD

Blood (2016) 128 (22): 3204.

https://doi.org/10.1182/blood.V128.22.3204.3204

Published: 2016

Journal Articles

Epidemiology of Fungemia in Hematological Malignancies: Preliminary Report of Seifem-2015 Survey

Blood (2015) 126 (23): 4887.

https://doi.org/10.1182/blood.V126.23.4887.4887

Published: 2015

Journal Articles

Bloodstream Infections Caused By Klebsiella Pneumoniae in Onco-Hematological Patients: Incidence and Clinical Impact of Carbapenem Resistance in a Multicentre Prospective Survey

Enrico Maria Trecarichi, MD, Mario Tumbarello, MD, Roberta Di Blasi, MD, Luana Fianchi, Simona Sica, Bruno Martino, MD, Anna Candoni, MD, Gianpaolo Nadali, MD, Domenico Pastore, Vincenzo Perriello, MD, Alessandro Busca, MD, Franco Aversa, MD, Rosa Fanci, MD, Lorella Melillo, MD, Federica Lessi, MD, Maria Ilaria Del Principe, MD, Chiara Cattaneo, Livio Pagano

Blood (2015) 126 (23): 3757.

https://doi.org/10.1182/blood.V126.23.3757.3757

Published: 2015

Journal Articles

MEN1112/OBT357, an Anti Bst1/CD157 Humanized Antibody Inducing Acute Myelogenous Leukemia (AML) Blast Depletion in an Autologous Ex Vivo Assay: A Potential New Targeted Therapy for AML

Adriano Venditti, MD, Francesco Buccisano, Luca Maurillo, MD, Maria Ilaria Del Principe, MD, Andrea Coppola, Patrizia Palomba, Roberto Arriga, Daniela Bellarosa, Alessandro Bressan, Keith Wilson, Stefano Manzini, Angela Capriati, MD PhD, Cecilia Simonelli, MD, Monica Binaschi, Sergio Amadori, MD, Giuseppe Sconocchia

Blood (2015) 126 (23): 788.

https://doi.org/10.1182/blood.V126.23.788.788

Published: 2015

Journal Articles

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

Francesco Buccisano, MD, Luca Maurillo, MD, Alfonso Piciocchi, Maria Ilaria Del Principe, MD, Gottardo De Angelis, MD, Ambra Di Veroli, MD, Raffaella Cerretti, MD, Mariagiovanna Cefalo, MD, Concetta Ditto, MD, Alessandra Picardi, MD, Laura Cudillo, MD, Benedetta Mariotti, MD, Francesco Lo Coco, MD, William Arcese, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2015) 126 (23): 3230.

https://doi.org/10.1182/blood.V126.23.3230.3230

Published: 2015

Journal Articles

Apoptosis and Proliferation Synergistically Determine Overall Survival in Chronic Lymphocytic Leukemia (CLL)

Giovanni Del Poeta, Michele Dal Bo, Francesco Buccisano, Federico Pozzo, Maria Ilaria Del Principe, MD, Pietro Bulian, Davide Rossi, MD PhD, Adriano Venditti, MD, Paolo de Fabritiis, Gianluca Gaidano, MD PhD, Sergio Amadori, MD, Valter Gattei

Blood (2015) 126 (23): 1718.

https://doi.org/10.1182/blood.V126.23.1718.1718

Published: 2015

Journal Articles

Bendamustine Improves Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) According to Different Clinical and Biological Prognostic Factors

Giovanni Del Poeta, Maria Ilaria Del Principe, MD, Dario Ragusa, Pietro Bulian, Francesco Buccisano, MD, Francesca Maria Rossi, Alessio Pio Perrotti, Luca Maurillo, MD, Paolo de Fabritiis, MD, Valter Gattei, Sergio Amadori, MD

Blood (2014) 124 (21): 5668.

https://doi.org/10.1182/blood.V124.21.5668.5668

Published: 2014

Journal Articles

Clinical Significance of Apoptosis in Chronic Lymphocytic Leukemia (CLL)

Giovanni Del Poeta, Maria Ilaria Del Principe, MD, Michele Dal Bo, Francesco Buccisano, MD, Dario Ragusa, Federico Pozzo, Pietro Bulian, Luca Maurillo, MD, Davide Rossi, MD PhD, Adriano Venditti, Paolo de Fabritiis, MD, Gianluca Gaidano, Sergio Amadori, Valter Gattei

Blood (2014) 124 (21): 834.

https://doi.org/10.1182/blood.V124.21.834.834

Published: 2014

Journal Articles

Age-Stratified Analysis Of The Prognostic Role Of Minimal Residual Disease Detection By Flow Cytometry, In Adult Patients With Acute Myeloid Leukemia

Francesco Buccisano, MD, Luca Maurillo, MD, Alfonso Piciocchi, PhD, Maria Ilaria Del Principe, MD, Chiara Sarlo, MD, Mariagiovanna Cefalo, MD, Concetta Ditto, MD, Ambra Di Veroli, MD, Daniela Nasso, MD, Marco Refrigeri, MD, Maria Antonietta Irno Consalvo, PhD, Daniela Fraboni, PhD, Consuelo Conti, Giovanni Del Poeta, MD, Francesco Lo Coco, MD, Sergio Amadori, Adriano Venditti, MD

Blood (2013) 122 (21): 2649.

https://doi.org/10.1182/blood.V122.21.2649.2649

Published: 2013

Journal Articles

In Acute Myeloid Leukemia, the Use in Induction of Standard Dose Arac Is Associated with a Better Quality of Response as Compared to An Induction Regimen Containing High Dose Arac.

Luca Maurillo, MD, Francesco Buccisano, M.D., Alessandra Spagnoli, Maria Ilaria Del Principe, MD, Benedetta Neri, MD, Chiara Sarlo, MD, Giovanni Del Poeta, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2009) 114 (22): 1584.

https://doi.org/10.1182/blood.V114.22.1584.1584

Published: 2009

Journal Articles

Flow-Cytometric Minimal Residual Disease Determination Is a Surrogate Prognosticator in Adult AML Patients Lacking Specific Molecular Signatures.

Francesco Buccisano, MD, Luca Maurillo, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Daniela Fraboni, PhD, Emanuele Ammatuna, MD, Maria Irno Consalvo, PhD, Paola Panetta, PhD, Licia Ottaviani, MD, Sabrina Faccia, MD, Manuela Rizzo, MD, Massimiliano Postorino, MD, Maria Cantonetti, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2007) 110 (11): 3498.

https://doi.org/10.1182/blood.V110.11.3498.3498

Published: 2007

Journal Articles

Detection of Minimal Residual Disease by Flow-Cytometry Otimizes Risk Stratification When Combined with Cytogenetics in AML.

Francesco Buccisano, MD, Luca Maurillo, MD, Giovanni Del Poeta, MD, Maria Ilaria Del Principe, MD, Paola Panetta, PhD, Daniela Fraboni, PhD, Maria Irno Consalvo, PhD, Daniela Renzi, MD, Selenia Campagna, MD, Chiara Sarlo, MD, Luca Franceschini, MD, Laura Giannì, MD, Emanuele Ammatuna, MD, Francesco Lo Coco, MD, Sergio Amadori, MD, Adriano Venditti, MD

Blood (2007) 110 (11): 4242.

https://doi.org/10.1182/blood.V110.11.4242.4242

Published: 2007

Journal Articles

Molecular and Clinical Features of B Cell Chronic Lymphocytic Leukemia (CLL) Carrying Stereotyped B Cell Receptors: An Italian Experience.

Blood (2007) 110 (11): 3089.

https://doi.org/10.1182/blood.V110.11.3089.3089

Published: 2007

Journal Articles

High CD49d Protein Expression Predicts Short Overall Survival and Early Progression in Chronic Lymphocytic Leukemia Patients.

Valter Gattei, MD, Pietro Bulian, MD, Maria Ilaria Del-Principe, MD, Antonella Zucchetto, BSci, Luca Maurillo, MD, Francesco Buccisano, MD, Riccardo Bomben, BSci, Michele Dal-Bo, BSci, Fabrizio Luciano, MD, Francesca M. Rossi, BSci, Massimo Degan, BSci, Sergio Amadori, MD, Giovanni Del-Poeta, MD

Blood (2007) 110 (11): 3097.

https://doi.org/10.1182/blood.V110.11.3097.3097

Published: 2007

NARROW

Infections in Patients with Lymphoproliferative Diseases Treated with Target Therapy. Italian Multicentric Retrospective Study Seifem 2017

Clinical Relevance of NOTCH1 Mutations in Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL)

The Amount of Apoptosis Predicts Outcome in Ibrutinib-Treated Chronic Lymphocytic Leukemia (CLL)

Clinical Significance of Occult Central Nervous System Disease in Adult ACUTE Lymphoblastic Leukemia. a Multicenter,Report from the Campus ALL/Gimema Network

Real Life Use of Bendamustine Plus Rituximab Versus Chlorambucil Plus Rituximab As Front-Line Therapy for Elderly CLL Patients. Retrospective Multicenter Study in the Lazio Region

Pattern of Central Nervous System (CNS) Involvement in Adult Acute Myeloid Leukemia (AML) and Its Impact on Outcome

Low Bax/Bcl-2 Ratio and NOTCH1 Mutations Represent Powerful and Synergistic Adverse Prognostic Factors within Trisomy 12 Chronic Lymphocytic Leukemia (CLL)

Epidemiology of Fungemia in Hematological Malignancies: Preliminary Report of Seifem-2015 Survey

Bloodstream Infections Caused By Klebsiella Pneumoniae in Onco-Hematological Patients: Incidence and Clinical Impact of Carbapenem Resistance in a Multicentre Prospective Survey

MEN1112/OBT357, an Anti Bst1/CD157 Humanized Antibody Inducing Acute Myelogenous Leukemia (AML) Blast Depletion in an Autologous Ex Vivo Assay: A Potential New Targeted Therapy for AML

Variable Outcome of Allogeneic Stem Cell Transplant According to the Different Levels of Pre-Transplant Minimal Residual Disease, in Adult Patients with Acute Myeloid Leukemia

Apoptosis and Proliferation Synergistically Determine Overall Survival in Chronic Lymphocytic Leukemia (CLL)

Bendamustine Improves Clinical Outcome in Chronic Lymphocytic Leukemia (CLL) According to Different Clinical and Biological Prognostic Factors

Clinical Significance of Apoptosis in Chronic Lymphocytic Leukemia (CLL)

Age-Stratified Analysis Of The Prognostic Role Of Minimal Residual Disease Detection By Flow Cytometry, In Adult Patients With Acute Myeloid Leukemia

In Acute Myeloid Leukemia, the Use in Induction of Standard Dose Arac Is Associated with a Better Quality of Response as Compared to An Induction Regimen Containing High Dose Arac.

Flow-Cytometric Minimal Residual Disease Determination Is a Surrogate Prognosticator in Adult AML Patients Lacking Specific Molecular Signatures.

Detection of Minimal Residual Disease by Flow-Cytometry Otimizes Risk Stratification When Combined with Cytogenetics in AML.

Molecular and Clinical Features of B Cell Chronic Lymphocytic Leukemia (CLL) Carrying Stereotyped B Cell Receptors: An Italian Experience.

High CD49d Protein Expression Predicts Short Overall Survival and Early Progression in Chronic Lymphocytic Leukemia Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only